Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FBXO3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HS2ST1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNHG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NUP160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DBN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TJP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM26F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLEC7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHCR24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB27A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF21B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOCS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMCO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDIAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on